Alexion Pharmaceuticals | 152.7500 / -0.59% |
Date/Time | 02/26 / 21:59 |
Chg. / Chg.(%) | -0.9000 / -0.59% |
Bid | 152.7000 / 100 |
Ask | 155.5000 / 600 |
Open | 153.2900 |
Previous Close | 153.6500 |
High | 153.8600 |
Low | 151.6000 |
Volume [USD] | 116,174,882.3413 |
Volume [Units] | 2,228,726 |
Price fixings | 6980 |
ISIN | US0153511094 |
Security | ALXN |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
TradeGate | 128.460 | ![]() |
40 |
Düsseldorf | 128.00 | ![]() |
0 |
Berlin | 127.70 | ![]() |
0 |
München | 127.40 | ![]() |
0 |
gettex | 127.240 | ![]() |
|
Lang & Schwa.. | 127.88 | ![]() |
|
Stuttgart | 127.880 | ![]() |
|
NASDAQ | 152.7500 | ![]() |
2,228,726 |
Cboe US | 152.90 | ![]() |
133,338 |
IEX | 152.86 | ![]() |
123,707 |
Vienna Globa.. | 126.28 | ![]() |
634 |
Mexico | 3,170.00 | ![]() |
611 |
Xetra | 125.78 | ![]() |
214 |
London Inter.. | 153.66 | 15 | |
Frankfurt | 125.8200 | 0 |
News
- Fortress Biotech Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
02/26/2021 / 14:00 - GlobeNewswire - CIO Leadership: Leveraging Advanced Technologies to Drive Business Success Will Guide the Conversation at HMG Strategy’s Upcoming 2021 HMG Live! Atlanta CIO Executive Leadership Summit
02/25/2021 / 16:42 - GlobeNewswire - Cyprium Therapeutics, a Fortress Biotech Partner Company, and Sentynl Therapeutics, a Wholly-owned Subsidiary of the Zydus Group, Sign Development and Asset Purchase Agreement for Cyprium Therapeutics’ Copper Histidinate Product Candidate for Treatment of Menkes Disease
02/24/2021 / 14:00 - GlobeNewswire - Zealand Pharma to participate in upcoming investor conferences
02/23/2021 / 22:05 - GlobeNewswire - Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer
02/22/2021 / 14:00 - GlobeNewswire